Innate Pharma
IPHA
$2.31
Share price
-6.85%
Change (1 day)
-21.69%
Change (1 year)
Categories
Earnings for Innate Pharma (IPHA)
Earnings in 2022: -$62.09 M
According to Innate Pharma 's latest financial reports the company's current earnings (TTM) are -$62.09 M. In 2022 the company made an earning of -$62.09 M a decrease over its 2021 earnings that were of -$51.51 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Innate Pharma from 2005 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 | -$62.09 M | 20.55% |
| 2021 | -$51.51 M | 4951.09% |
| 2020 | -$1.02 M | -111.57% |
| 2019 | $8.81 M | 183.46% |
| 2018 | $3.1 M | -105.39% |
| 2017 | -$57.65 M | -523.13% |
| 2016 | $13.62 M | -285.79% |
| 2015 | -$7.34 M | -69.31% |
| 2014 | -$23.9 M | 498.29% |
| 2013 | -$4 M | -5.62% |
| 2012 | -$4.24 M | -53.22% |
| 2011 | -$9.05 M | -50.21% |
| 2010 | -$18.17 M | -13.3% |
| 2009 | -$20.96 M | 26.36% |
| 2008 | -$16.59 M | 27.35% |
| 2007 | -$13.03 M | 63.03% |
| 2006 | -$7.99 M | 10.28% |
| 2005 | -$7.25 M |